Outset Medical (OM) Change in Account Payables (2019 - 2026)
Outset Medical's (OM) quarterly Change in Account Payables came in at $865000.0 in Q1 2026, up 131.2% year-on-year from $374127.0 in Q1 2025, and up 176.62% on a QoQ basis from -$1.1 million in Q4 2025.
Outset Medical (OM) Change in Account Payables (2019 - 2026) Analysis & Trends
Outset Medical (OM) has 8 years of Change in Account Payables data on file, last reported at $865000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 131.2% year-over-year to $865000.0 in Q1 2026; TTM through Mar 2026 was $344000.0, a 106.07% increase from a year earlier, with the FY2025 full-year figure at -$3.3 million, down 69.05% from the prior year.
- Change in Account Payables for Q1 2026 stood at $865000.0, up from -$1.1 million in the prior quarter.
- Over the last five years, Change in Account Payables for OM reached as high as $3.3 million in Q1 2022 and fell as low as -$2.8 million in Q1 2025.
- Historically, Change in Account Payables has averaged -$20294.1 across 5 years, with a median of $207000.0 in 2023.
- Across the five-year window, Change in Account Payables soared 533.57% in 2023 and slumped 819.32% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at -$706000.0 in 2022, then surged by 533.57% to $3.1 million in 2023, then plunged by 114.41% to -$441000.0 in 2024, then slumped by 156.01% to -$1.1 million in 2025, then soared by 176.62% to $865000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $865000.0 in Q1 2026, -$1.1 million in Q4 2025, and $338000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | 221.00 Mn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | - |
| 10 | Outset Medical | 78,728.30 | -286.57 Mn | 12.10 Mn | 865,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 865,000.00 |
| Mar 31, 2026 | 865,000.00 |
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | 338,000.00 |
| Sep 30, 2025 | 338,000.00 |
| Jun 30, 2025 | 270,000.00 |
| Jun 30, 2025 | 270,000.00 |
| Mar 31, 2025 | -2.77 Mn |
| Mar 31, 2025 | -2.77 Mn |
| Dec 31, 2024 | -441,000.00 |
| Dec 31, 2024 | -441,000.00 |
| Sep 30, 2024 | -963,000.00 |
| Sep 30, 2024 | -963,000.00 |
| Jun 30, 2024 | -1.49 Mn |
| Jun 30, 2024 | -1.49 Mn |
| Mar 31, 2024 | 945,000.00 |
| Mar 31, 2024 | 945,000.00 |
| Dec 31, 2023 | 3.06 Mn |
| Dec 31, 2023 | 3.06 Mn |